Literature DB >> 21798468

Pregnancy in women with heart disease in sub-Saharan Africa.

Maboury Diao1, Adama Kane, Mouhamadou Bamba Ndiaye, Alassane Mbaye, Malick Bodian, Mouhamadoul Mounir Dia, Moustapha Sarr, Abdoul Kane, Jean-Jacques Monsuez, Serigne Abdou Ba.   

Abstract

BACKGROUND: Although previous studies showed that pregnancy with heart disease is associated with significant complications, few focused on patients with valvular heart disease in sub-Saharan Africa.
METHODS: We report maternal and foetal outcomes in 50 pregnant women with heart disease admitted to the Department of Cardiology of the University of Dakar, during an 8-year period.
RESULTS: Rheumatic heart disease was observed in 46 women, seven of whom had previously been operated on. Among the remaining 39, 32 had mitral stenosis (isolated or associated with other valvular lesions). At admission, 36 women presented with pulmonary oedema, two with pulmonary embolism and 18 with arrhythmia. There were 17 maternal deaths (34%). Maternal death was associated with: mitral stenosis (P=0.03); severe tricuspid regurgitation (P=0.001); New York Heart Association functional class III or IV (P=0.001); symptoms of heart failure (P<0.001). A favourable maternal outcome was associated with: prior cardiac events (P<0.001); prior surgical valve replacement (P=0.03); cardiac prosthetic valve (P=0.03). There were 30 live births, six foetal deaths and five therapeutic abortions; nine women were lost to follow-up. Delivery was vaginal in 19 out of 30 cases and by caesarean section in 11 cases. Median gestational age at delivery was 28weeks (range, 8-38weeks). Five births occurred preterm. There were four stillbirths (neonatal mortality, 7.6%).
CONCLUSIONS: Heart disease severely impacts maternal and foetal outcome in our study. Pregnant women who underwent appropriate valve replacement before pregnancy had a better prognosis.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21798468     DOI: 10.1016/j.acvd.2011.04.001

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  34 in total

Review 1.  Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis.

Authors:  Liesl Zühlke; Bongani M Mayosi
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

Review 2.  Acute rheumatic fever and rheumatic heart disease.

Authors:  Jonathan R Carapetis; Andrea Beaton; Madeleine W Cunningham; Luiza Guilherme; Ganesan Karthikeyan; Bongani M Mayosi; Craig Sable; Andrew Steer; Nigel Wilson; Rosemary Wyber; Liesl Zühlke
Journal:  Nat Rev Dis Primers       Date:  2016-01-14       Impact factor: 52.329

Review 3.  Rheumatic heart disease: current status of diagnosis and therapy.

Authors:  Ferande Peters; Ganesan Karthikeyan; Jessica Abrams; Lorrein Muhwava; Liesl Zühlke
Journal:  Cardiovasc Diagn Ther       Date:  2020-04

4.  Rheumatic fever with severe carditis: still prevalent in the South West Pacific.

Authors:  Taran Kaur Nandra; Nigel J Wilson; John Artrip; Bruno Pagis
Journal:  BMJ Case Rep       Date:  2017-03-10

Review 5.  Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease.

Authors:  Bo Remenyi; Jonathan Carapetis; Rosemary Wyber; Kathryn Taubert; Bongani M Mayosi
Journal:  Nat Rev Cardiol       Date:  2013-04-02       Impact factor: 32.419

6.  Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study).

Authors:  Liesl Zühlke; Mark E Engel; Ganesan Karthikeyan; Sumathy Rangarajan; Pam Mackie; Blanche Cupido; Katya Mauff; Shofiqul Islam; Alexia Joachim; Rezeen Daniels; Veronica Francis; Stephen Ogendo; Bernard Gitura; Charles Mondo; Emmy Okello; Peter Lwabi; Mohammed M Al-Kebsi; Christopher Hugo-Hamman; Sahar S Sheta; Abraham Haileamlak; Wandimu Daniel; Dejuma Y Goshu; Senbeta G Abdissa; Araya G Desta; Bekele A Shasho; Dufera M Begna; Ahmed ElSayed; Ahmed S Ibrahim; John Musuku; Fidelia Bode-Thomas; Basil N Okeahialam; Olukemi Ige; Christopher Sutton; Rajeev Misra; Azza Abul Fadl; Neil Kennedy; Albertino Damasceno; Mahmoud Sani; Okechukwu S Ogah; Taiwo Olunuga; Huda H M Elhassan; Ana Olga Mocumbi; Abiodun M Adeoye; Phindile Mntla; Dike Ojji; Joseph Mucumbitsi; Koon Teo; Salim Yusuf; Bongani M Mayosi
Journal:  Eur Heart J       Date:  2014-11-25       Impact factor: 29.983

7.  Health policy: Reducing rheumatic heart disease in Africa -- time for action.

Authors:  Andrea Beaton; Craig Sable
Journal:  Nat Rev Cardiol       Date:  2016-03-03       Impact factor: 32.419

Review 8.  Valvular Heart Disease and Pregnancy.

Authors:  Emily S Lau; Nandita S Scott
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-04-26

Review 9.  Endovascular Therapy for Rheumatic Mitral and Aortic Valve Disease: Review Article.

Authors:  Tesfaye Telila; Elsayed Mohamed; Kurt M Jacobson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-06-22

10.  Percutaneous mitral commisurotomy during pregnancy - A report of two cases performed in a United Kingdom tertiary centre and a review of the literature.

Authors:  Dipanwita Kapoor; Ferrah Choudhary; William Ht Smith; Suzanne Wallace
Journal:  Obstet Med       Date:  2015-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.